Abstract:Abstract Background Circulating cell-free DNA (cfDNA) methylation has been demonstrated to be a promising approach for non-invasive cancer diagnosis. However, the high cost of whole genome bisulfite sequencing (WGBS) hinders the clinical implementation of a methylation-based cfDNA early detection biomarker. We proposed a novel strategy in low-pass WGBS (~ 5 million reads) to detect methylation changes in circulating cell-free DNA (cfDNA) from patients with liver diseases and hepatocellular carcinoma (HCC). Methods The effective small sequencing depth were determined by 5 pilot cfDNA samples with relative high-depth WGBS. CfDNA of 51 patients with hepatitis, cirrhosis, and HCC were conducted using low-pass WGBS. The strategy was validated in an independent WGBS cohort of 32 healthy individuals and 26 early-stage HCC patients. Fifteen paired tumor tissue and buffy coat samples were used to characterize the methylation of hepatitis B virus (HBV) integration regions and genome distribution of cfDNA. Results A significant enrichment of cfDNA in intergenic and repeat regions, especially in previously reported HBV integration sites were observed, as a feature of cfDNA and the bias of cfDNA release. Methylation profiles nearby HBV integration sites were a better indicator for hypomethylation of tumor genome comparing to Alu and LINE (long interspersed nuclear element) repeats, and were able to facilitate the cfDNA-based HCC prediction. Hypomethylation nearby HBV integration sites (5 kb flanking) was detected in HCC patients, but not in patients with hepatitis and cirrhosis (Methyl HBV5k , median:0.61 vs 0.72, P = 0.0003). Methylation levels of integration sites certain candidate regions exhibited an area under the receiver operation curve (AUC) value > 0.85 to discriminate HCC from non-HCC samples. The validation cohort achieved the prediction performance with an AUC of 0.954. Conclusions Hypomethylation around viral integration sites aids low-pass cfDNA WGBS to serve as a non-invasive approach for early HCC detection, and inspire future efforts on tumor surveillance for oncovirus with integration activity.

BS-virus-finder: Virus Integration Calling Using Bisulfite Sequencing Data

Genome-scale sequence data processing and epigenetic analysis of DNA methylation]

A Comprehensive Evaluation of Alignment Software for Reduced Representation Bisulfite Sequencing Data

A New Approach to Decode DNA Methylome and Genomic Variants Simultaneously from Double Strand Bisulfite Sequencing.

Valibs: A Visual Aligner for Bisulfite Sequences

BS-RNA: An efficient mapping and annotation tool for RNA bisulfite sequencing data

Detecting Virus Integration Sites Based on Multiple Related Sequencing Data by VirTect

Study on detection of CNVs using human whole genome bisulfite sequencing data

SurVirus: a repeat-aware virus integration caller

LiBis: an ultrasensitive alignment augmentation for low-input bisulfite sequencing

bsgenova: an accurate, robust, and fast genotype caller for bisulfite-sequencing data

Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing

A Bayesian Framework to Identify Methylcytosines from High-Throughput Bisulfite Sequencing Data

HIVID2: an accurate tool to detect virus integrations in the host genome

Approaches for the Analysis and Interpretation of Whole-Genome Bisulfite Sequencing Data

BatMeth: Improved Mapper for Bisulfite Sequencing Reads on DNA Methylation.

BSXplorer: analytical framework for exploratory analysis of BS-seq data

VirusPredictor: XGBoost-based software to predict virus-related sequences in human data

SegFinder: an automated tool for identifying RNA virus genome segments through co-occurrence in multiple sequenced samples

Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications

HPV, HBV, and HIV-1 Viral Integration Site Mapping: A Streamlined Workflow from NGS to Genomic Insights of Carcinogenesis